Ischemic Stroke
Conditions
Interventions
Early Neurological Deterioration Group:None
Control Group:None
Sponsors
Beijing Tsinghua Changgung Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Symptomatic acute ischemic stroke (including first/recurrent stroke); 3.Successful completion of peripheral blood sample collection for blood tests within 24 hours of admission (for patients undergoing thrombolysis/endovascular treatment, blood samples thrombolysis/endovascular treatment should be collected), including 2 tubes of EDTA-anticoagulated blood and 1 tube of sodium citrate-anticoagulated blood; for hospitalized patients, blood samples collected at multiple time points as needed after admission, including 2 tubes of EDTA-anticoagulated blood and 1 tube of sodium citrate-anticoagulated blood. 4.Detailed clinical data recording.
Exclusion criteria
Exclusion criteria: 1.Hemorrhagic stroke; 2.Comorbid serious systemic diseases that may affect life expectancy, including cancer, cardiopulmonary or hepatic/renal failure, etc.; 3.Infectious disease within 14 days prior to symptom onset; 4.Comorbid immunosuppression or use of immunosuppressive drugs; 5.Incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early Neurological Deterioration in Retrospective study;Early Neurological Deterioration in Prospective study; | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary indicators are not included in retrospective study.;Secondary indicators are not included in prospective study.; | — |
Countries
China
Contacts
Public ContactJian Wu
Beijing Tsinghua Changgung Hospital
Outcome results
None listed